Organigram reported $247.2 million in gross revenue and $159.8 million in net revenue for fiscal year 2024, ended September 30, but a net loss of $45.4 million.
This represents an increase from $233.6 million in gross revenue for the previous fiscal year (which was 13 months), $161.6 million in net revenue, and a $248.6 million net loss. Organigram reports incurring $87.3 million in excise taxes in fiscal year 2024.
The company’s gross margins nearly doubled in the most recent fiscal year, from 16% to 30%, while operating expenses were down significantly.
The most significant growth in sales for Organigram in fiscal year 2024 were adult-use, recreational non-medical sales of cannabis flower and infused pre-rolls.
In that category, cannabis flower sales, net of excise duty, were $91.2 million, up from $82.1 million in the previous year. Vapes were $2.2 million, down from $3.8 million in 2023. Hash was relatively level at $11.3 million, compared to $11.2 million in 2023. Infused pre-rolls jumped significantly to $12.2 million from just $2.9 million the previous year. Edibles were $21.4 million, compared to $22.1 million in 2023. Ingestible oils and extracts were $4.7 million, up from $4.3 million.
On the medical use supply chain side, sales dropped from nearly $3 million in 2023 to $1.7 million in 2024, while sales of flower and oil on the international market dropped from $18.9 million in 2023 to $9.7 million in 2024. Wholesale and other sales were $5.4 million compared to $2.1 million in 2023.
Since Q4 2023, the amount of dried flower yield per plant in grams and flower harvested in kilograms has increased or stayed level, quarter over quarter.
Organigram’s net revenue in Q4 2024 was the highest the company has reported in the preceding eight quarters.
As of September 30, 2024, the company had unrestricted cash of $133,426, up from $51,757 at September 30, 2023. The company attributes the increase primarily to the proceeds from the follow-on British American Tobacco (BAT) investment and the offering of units that closed on April 2, 2024.
In December, following the end of the most recent fiscal reporting period, Organigram also acquired Motif which included a cash component of approximately $50 million and roughly $5 million in transaction costs. The funds to finance this acquisition were not drawn from the Jupiter Pool created by BAT.
The acquisition of Motif made Organigram the number-one LP in Canada in terms of market share. It also added two purpose-built facilities to its portfolio, focusing on cannabis extraction, processing, manufacturing, and distribution.
Organigram expects to close the third tranche from the follow-on BAT investment in the amount of $41.5 million on or about February 28, 2025.
“Fiscal 2024 was a transformative year where our entire team delivered on multiple fronts,” said Organigram’s CEO Beena Goldenberg. “We received significant funding from BAT when capital for the cannabis industry was scarce. We made smart, strategic investments, including into seed-based technology and automation, which is increasing efficiency. We have also expanded our international footprint through a $21 million investment in Sanity Group, a leading German cannabis company, as well as through several new supply agreements to provide products to patients in Australia and the UK. As we integrate recently-acquired Motif into the Organigram ecosystem, we head into Fiscal 2025 as Canada’s #1 LP and we are very excited for the next phase of our growth plans focused on efficiency, consumer-centric innovation, and international expansion.”
Organigram’s biggest brand, SHRED, brought in $225 million in annual retail sales as of the end of Q4 Fiscal 2024.
Organigram sells into four international medical supply markets: Australia, Germany, the UK, and Israel, and has completed an investment in a German cannabis leader, Sanity Group, to establish a foothold in the growing European cannabis market. The company has also completed strategic investments in two U.S.-based companies: OBX and Phylos.
Organigram also completed its EU-GMP audit in November 2024, and is awaiting the results.
A report of an independent registered public accounting firm, included in Ogranigram’s annual report, says the Moncton-based cannabis company has not maintained effective internal control over financial reporting as of September 30, 2024, based on criteria established in Internal Control-Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway (COSO.)
Some of my earliest memories are of hanging out with my mum in our garden. Together, we would plant seeds and watch the baby plants poke their heads above the soil—and I knew that life was good.
After moving to a city, I forgot about the real magic that takes place when food grows from the soil. I took my vegetables for granted, and life was busy. Who has space for growing food in a city, anyway?
In my 20s, I discovered microgreens at a farmers’ market. I was impressed that the ‘superfood’ baby salad leaves had been grown hydroponically on shelving units in an indoor ‘vertical farm.’ I fell in love with these tiny – and expensive – plants and set about growing them myself.
Before long, I had set up a business, rented a basement unit in central Bristol in the UK, and cycled around the city delivering microgreens to local restaurants. Urban farming had my heart – but I knew microgreens wouldn’t feed the world. And the mushrooms were calling me.
Why Grow Mushrooms?
Mushrooms have existed for over a billion years—long before plants and animals existed. They’re getting a lot of attention now—among foodies, health seekers, and ecologists alike—and this is good news. We need their help.
Fungi have been used as foods, medicines and spiritual tools for thousands of years. They can boost immunity, improve cognitive function and help heal our bodies and minds. They are also super-digestors that can clear up oil spills and harmful chemicals like pesticides. With millions of species still yet to be discovered, who knows what other magic there is in the Kingdom of Fungi?
Also, they’re delicious. And you can grow a lot of them in a tiny space.
Now, I teach other people to grow mushrooms at home, and I’ll tell you more about how to do it in future copies of Garden Culture Magazine. First, let’s look at how mushrooms are commonly cultivated indoors.
How to Grow Mushrooms at Home
Most mushrooms can be grown relatively easily at home with little equipment. Different species have varying appetites and specific preferences, but generally, most mushrooms are cultivated using the three stages below.
Making Mushroom “Seeds”
Mushrooms don’t have real seeds – but grow from mycelium – so this needs to be cultivated in a highly nutritious environment to act as ‘seeds’ for planting. A common way to do this is to inject spores into sterile grain – and store them in a warm, dark place for a few weeks until the grain turns white. At this stage, spores germinate and ‘colonise’ – so that each grain becomes filled with energised mycelium.
Then your ‘seeds’ are ready for stage 2…
Planting and Nurturing “Seeds” in “Soil”
When your grain is white, you can break it up and mix it with a ‘substrate’ (mushroom ‘soil’), which differs depending on the variety of mushrooms being grown. Examples of different ‘soils’ are straw, hardwood pellets (or actual logs), coconut coir, vermiculite and manure. The soil/seed mix is poured into a container like a lunchbox, tub or bag and left for a few more weeks until it has all turned into a white block.
Then, you’re ready for the exciting bit…
Growing – or “Fruiting” – Mushrooms!
Now is the moment to take your container out of its ‘underground’ phase and encourage it to push out some mushrooms! At this stage, you will effectively simulate Autumn/Fall by introducing light, slightly reducing the temperature, and increasing the humidity and fresh air inside your container. You can use ambient daylight (or LEDs), ‘waft’ fresh air into your containers, and humidify with a water mister.
Now, all that’s left is to harvest, preserve and enjoy. You can put your container back into fruiting conditions as they often produce multiple flushes of mushrooms.
Stay tuned for more specific guides from Alex in future issues of Garden Culture Magazine.
Alex has developed a step-by-step course that is available now on UDEMY.
Cannabis financing has long been viewed as a complex and daunting challenge, largely due to the industry’s unique regulatory framework, market volatility, and limited access to traditional financial services. Having said that, as the market matures, more and more financing options will make their way into boardroom discussions as real scenarios instead of abstract ideas.
Some of the traditional and reliable ways to infuse capital include debt financing, equity, and working capital loans. But how does one even know which of those are applicable and effective?
“An indicator that debt financing may be necessary is when a company, whose business valuation has been affected by market conditions, seeks to raise capital without issuing new shares in order to retain maximum ownership,” says Dominic Daigle, managing partner of Agile Solutions, a Canadian-based financing firm that raises funds in various sectors including cannabis. “In that instance, debt financing could be a good way to preserve ownership of the company.”
Daigle adds that in 2018, at the time of legalization in Canada, cannabis companies had incredibly high valuations, some in the hundreds of millions. Now, when looking at the market, the scenery is quite different with valuations at a sliver of what they once were. This is why equity financing can prove to be a challenge right now.
Advertisement
“If you want to raise $5 million and your company is worth $10 million, you need to sell 50% of your company,” he says. “In 2018 if you were worth $100 million and you needed $5 million, you would just lose five percent.”
Another challenge in the In the Canadian cannabis sector lies in the fact that receivables often extend beyond 30 days, with some invoices taking up to 60 or even 90 days to be paid. This delay can strain a company’s cash flow, particularly for smaller producers and ancillary businesses that need consistent working capital to manage operating costs, payroll, and inventory.
If this sounds familiar, invoice factoring offers an effective solution by enabling businesses to sell their outstanding invoices to a third party at a discount. It provides immediate cash flow without waiting for customers to pay, ensuring smooth operations while mitigating the risk of late payments. This is especially beneficial in a sector where payment terms can vary significantly depending on the size and liquidity of the buyer.
“We know in the cannabis industry most provinces pay in more than 30 days,” says Daigle. “If your client is not paying you at the time of the order and you need to give payment terms, you should consider invoice factoring.”
Advertisement
There is also the option of a straight working capital loan, which can be a vital financial tool for cannabis companies in Canada, providing the necessary funds to cover operational expenses, such as payroll, rent, inventory, and marketing, during periods of fluctuating revenue.
With the highly regulated nature of the cannabis industry and ongoing challenges like seasonal demand and competition from unlicensed markets, access to flexible financing ensures businesses can maintain steady growth and manage cash flow effectively.
“As a general guideline, the fastest type of loan we have successfully funded in the cannabis industry offers the opportunity to access one to two months of revenue, amortized over 12 months, without requiring collateral,” said Daigle. “Let’s say a company is making $1.2 million annually; we can secure them a loan of $100,000 to $200,000 in about 5 days.”
Make Hay While the Sun Shines
Advertisement
Cannabis companies may want to consider seeking financing proactively, when their financial situation is stable, rather than waiting until cash flow issues arise.
Securing financing when a company is financially healthy allows for more favorable terms, greater lender confidence, and the ability to plan for growth opportunities without the pressure of an immediate cash crunch. Conversely, waiting until a company is struggling can limit financing options and result in higher interest rates or stricter terms, as lenders may perceive greater risk. This is especially important in the cannabis sector, where market volatility, delayed receivables, and regulatory changes can rapidly impact liquidity.
“The best time to get financing options is when you think you don’t need them,” says Daigle. “Don’t wait until you need it.”
Welcome to the wonderful world of cultivation. This Winter issue features several pro growers from the Canadian cannabis industry, including our Top Grower spotlights Gerrit Richards and Patrick Pagé, Rob Baldwin author of our cultivation column, Q&A subject Wade Forrest, and the LPs featured in the stories byAly K. Benson and Joe Navarro.
This season we bring you the winners of our fifth annual Top Grower Award. To celebrate, Top Grower sponsor CANNA provided two branded BMX bikes (ontop of their usual swag) and I couldn’t think of two more deserving lads. Congratulations Patrick and Gerrit!
Thank you Top Grower sponsor Biofloral, for supporting this contest and for providing an essential service to the domestic market – outfitting so many of our cultivators with top shelf supplies and guidance.
Advertisement
I’d also like to thank our panel of judges. OG grower David Kjolberg has scored the contest candidates since its inception. Thank you to three-time returning judge and award-winning master grower Stacie Hollingworth, two-time judge and expert of the highest integrity, Av Singh, and first year judge and winner of our 2022 award, Alexandre Gauthier. I’m happy to close 2024 with a focus on the heart of this industry, the growers. To toast and take a closer look at how it is we all got here.
This year we highlight one standard and one micro-LP winner. Two men representing the Eastern and Western conferences, equally: an Anglophone from Quebec and a B.C. boy from Alberta. There’s a parallel between the two profiles, including how they got their start in cannabis, trimming at Aurora facilities, and meeting and working alongside their dedicated partners. They are the women who nominated them for this award, Beth Talbot and Mehgan Race Widdison, growers who go above and beyond in performance and attention to detail. If it wasn’t for them, we wouldn’t have gotten to hear these tales of dedication to soil biology and the evolution of a refined pallet, respectively.
I’m always inspired when I speak to young talent who have moved into serious leadership roles and are helping others along the way. This industry should be proud of the legacy knowledge it retained and the networks forged among growers of all ages and stages in their career development. To the folks who learn the ropes of a corporate environment even if it goes against their nature. It is a powerful thing, integrating a skill you didn’t know you were made for and then putting your own spin on it. Something perhaps I explored during my time as editor of Grow Opportunity magazine.
This is the 12th and final magazine I’ll be putting out for this beloved brand as I carry on the road of my own story.
Advertisement
There is room for B2B storytelling in this space, and the people are still here to read long-form human interest piecesdespite constant inundation with bites of information. Thank you to the many folks of varying expertise I’ve spoken to and called upon over the last few years, to my colleagues at Annex Business Media for taking a chance on me, and above all, thank you to the sweet cannabis plant in all her otherworldly glory.
Thank you for inspiring in all of us the creative avenues that are the spice of this life – the titillations made bold enough to follow, and for fostering an interest in gardening that for some like me, provide a powerful bridge to stewardship of the natural world. To be frank, I’m still not entirely sure of my grasp on the nuts and bolts of cannabis as an industry, but I can be sure of my place in it.
Finally, Denis Gertler writes about potential growth opportunities in the sector using the blue ocean strategy analogy, supported by this Socrates quote: “The secret of change is to focus all of your energy not on fighting the old, but on building the new.”While likened to business possibilities in cannabis, I just think they’re sound words to live by.
Psychedelics like LSD, psilocybin, ayahuasca, and MDMA have demonstrated potential in managing conditions like addiction, post-traumatic stress disorder, and depression. These drugs can give rise to profound experiences that, when paired with talk therapy, may bring about substantial therapeutic benefits.
This has grown the popularity of psychedelic-assisted therapy as more and more studies tout the benefits of this approach, particularly for patients with mental health conditions who’ve gained no benefit from traditional treatments.
Now new research by investigators at the University Medical Center Gröningen and the Champalimaud Foundation calls to attention gaps in how the psycho-therapeutic aspect of these therapies is described, possibly impeding their safety and effectiveness. For their research, the investigators systematically reviewed forty-five studies which involved more than 1400 participants to evaluate how well the psychological interventions were reported.
They found that psychological interventions varied extensively across studies and were poorly reported in most cases, with many lacking detailed data about the qualifications of therapists involved, specific methods used, and the therapy model setting. Important details like the number of therapy sessions, which is crucial for determining the amount of therapy required for effective treatment, was often disregarded.
While the quality of the therapist-patient relationship is known to influence the effectiveness of psychotherapy, other factors also play a crucial role in patient outcomes.
Carolina Seybert, the first author of the study, explained that measuring how closely therapists followed treatment protocols was necessary for ensuring effectiveness and safety. However, most studies didn’t track adherence as it was both time-consuming and costly, which made it hard for investigators to determine whether therapy was delivered as intended.
The investigators also found that unlike ayahuasca and psilocybin studies, MDMA research had higher reporting quality because they used one standardized manual for treatment.
In their report, the investigators explained that having clear guidelines could enhance how interventions were reported, noting that this would help other researchers to better understand which psychological interventions were most effective for certain mental conditions while also enabling them to deliver psychedelic-assisted psychotherapy in a way that enhanced its applicability in practical settings.
Seybert added that improving reporting standards would better guide professional boards and clinicians on the competencies, training, and experience required to deliver these treatments effectively and safely.
One of the study’s senior authors, Albert Oliveira-Maia, then noted that since reporting was already improving, regulatory authorities would have access to more data required to make informed decisions. The investigators’ findings were reported in the Lancet journal.
Entities like Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) need to analyze these research finding closely and see whether any of the recommendations made can help them during their own psychedelic medicine development.
About PsychedelicNewsWire
PsychedelicNewsWire (“PNW”) is a specialized communications platform with a focus on all aspects of psychedelics and the latest developments and advances in the psychedelics sector. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, PNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, PNW brings its clients unparalleled recognition and brand awareness. PNW is where breaking news, insightful content and actionable information converge.
To receive SMS alerts from PsychedelicNewsWire, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
A researcher with the Vancouver Coastal Health Research Institute and the University of British Columbia is recruiting people who use cannabis for medical purposes for a driving simulation study.
The study, which plans to begin recruiting for participation in early 2025, is being led by Dr. Jeff Brubacher, the director of the Vancouver General Hospital Emergency Medicine Research Program. Brubacher is also director of the Road Safety and Public Health Research Lab at the University of British Columbia (UBC), and professor in the UBC Department of Emergency Medicine.
The goal of the study is to look at two separate streams of medical cannabis users: Those who are just starting to use cannabis for medical purposes and those who have been using it for this purpose prior to the study.
In the first stream, those with no prior medical cannabis use will be tested before beginning their use of cannabis, then again after the onset of use after one month and four months.
Brubacher explains this will help provide a baseline of participants’ driving abilities, giving a better understanding of how cannabis use might impact them. While impairment from cannabis is one factor to consider, he also notes that some who are using cannabis for medical purposes are doing so to help transition away from opioids or benzodiazepines, which could mean impairment could potentially decrease following cannabis use.
“The question is, what happens to your driving after you start medical cannabis,” he explains. “Did you get better or did it get worse?”
The second stream of study participants will be recruited from people already using cannabis for medical purposes with authorization from a medical professional. Similarly, the goal with this cohort will be to measure the impact of cannabis use on their abilities to drive, as well as taking specific cognitive tests.
Cannabis users will be asked to abstain from taking any cannabis products the night prior to the study. On the day of the study, they will take the tests before using cannabis and then again after 30 minutes, two hours, four hours, and six hours.
“The question there is, after I take my regular cannabis, do I have some driving impairment or not,” said Brubacher. “And if I have it, when does it occur and how long does it last?”
Driving abilities will be monitored using the High Fidelity Driving Simulator, measuring for things such as speed, weaving, reaction time, and collisions. The study will be conducted at the Vancouver General Hospital campus in Vancouver.
In addition, researchers will take blood samples from participants to determine the level of detectable THC in their system. This will not only provide researchers with a correlation between participants’ results on the driving simulator but also give participants a better understanding of their blood/THC levels at any given time, especially after they have abstained overnight.
This is especially important, he notes, since THC can linger in the blood sometimes well after any impairing effects have passed. The allowable legal limit in Canada is less than 2 nanograms (ng) of THC per millilitre of blood.
“How many people are driving around with a THC level that is illegal—above 2 nanograms per millilitre for example— but are totally unimpaired?” he asked. “I think we have to look at that because it’s not fair or just for someone to be on prescribed medication and be at risk that if anything happens and they get tested, there could be legal implications. So I think knowing their THC levels when they’re not impaired will be interesting.”
The Canadian Institute of Health Research (CIHR) is funding the research. It is seeking to recruit 360 medical cannabis users for the study, which is expected to take around three years.
Brubacher and his team are also working with Vancouver-area medical cannabis clinic Green, Leaf Medical Clinic to recruit participants for the study.
Working with the clinic’s medical director, Dr. Carolyn MacCallum’s patients who fit the parameters of the study will be given a chance to participate.
Fonda Betts, the clinic’s CEO, says she and her team are excited to be a part of the project and highlight the need for this type of research. While there has been similar research looking at non-medical cannabis users, building a set of data that looks at how cannabis use impacts driving abilities, if at all, is important.
“It’s a little different when you’re using it as a medical patient compared to recreational cannabis use. A medical patient is using it for symptom management, a better quality of life, whereas a recreational user may be used to being impaired, using cannabis to get high.”
The goal for a medical cannabis user under the guidance of a medical professional at Green Leaf is to achieve what she says is a goal of finding beneficial effects for the user before reaching a level that impairs the person.
“This study, I hope, will help show that medical cannabis will have little to no impact on driving abilities. That’s our hope. So if we can provide the data to support that, it can reassure patients, health care professionals, and the public that medical patients are using it safely.”
Those interested in taking part in the study can reach out here: [email protected].
In 2016, the Canadian Human Rights Tribunal ruled that Canada discriminated against First Nations children by underfunding on-reserve child and family services and ignoring Jordan’s Principle. In February 2024, Canada offered $47.8 billion to address the issue where Chiefs at a Special Meeting of the Assembly of First Nations rejected the deal over concerns of structural flaws and lack of consultation in the negotiations. This matter has also been exposing the existing rift between the AFN as a corporate entity and the Chiefs in Assembly in regards to representation and legal jurisdiction.
More on this Issue:
Prime Minister Justin Trudeau takes questions at an Assembly of First Nations annual Special Assembly in Ottawa, Thursday December 5th 2024. Photo: Radio Canada, Marie-Laure Jossein
What I share here is not about the specifics of the back n forth bantering nor is this a critical analysis of the deal itself as these issues only keep us distracted, divided to remain under the subjugation of Canada’s Jurisdiction. What I am providing here is what Indigenous academics, advocates, activists and so called leaders are failing to address if we truly really being honest about the restoration of our jurisdiction and self determination.
Many Chiefs feels the AFN no longer represents them and is only an extension of Indigenous Services Canada. In 2020-2021 the AFN was funded $34 Million from Canada to administer programs for Indigenous Services Canada.
The Act Respecting First Nations, Inuit, and Métis Children, Youth and Families, was implemented on January 1, 2020 to address the overrepresentation of Indigenous children in “care” across the country. On February 9, 2024, the Supreme Court of Canada unanimously ruled that provisions within this act are constitutionally protected. The ruling affirmed that Indigenous peoples have an inherent right to jurisdiction of child and family services. As it appears our jurisdiction has been recognized and affirmed however the fact remains that we are still under Canada’s Jurisdiction.
It has always been our experience with our European guests that their languages are “forked-tongued” and used for deception. The use of the word “Inherent” is now being attached to “rights” and “jurisdiction” to deceive. The legal definition of a “person” means a corporation and not the living human being. The 1982 Constitution Act is in name only and is not a constitution; It is only an enactment of a foreign monarchy and government that had no legal authority to enact anything for a free and independent people. The 1982 Constitution Act is only a charter for a corporation.
Canada’s 1982 Constitution Act never defined Indigenous and Treaty Rights where these rights are being defined through Supreme Court decisions that rely on case law that set precedence for the Doctrine of Discovery. All Indigenous and Treaty Rights recognized by the Supreme Court and under Section 35 of the Charter of Rights and Freedoms ultimately affirms Canada has jurisdiction over all Indians and Indian lands.
Canada’s recognition of First Nations inherent right to self government in regards to jurisdiction of child and family services is no different then First Nations inherent right to jurisdiction of policing services; We are only in control of the apprehending and still remain under Canada’s jurisdiction as “Indians” and the legal person.
The followings laws shows how the birth certificate holds us in servitude to the State and extinguishes our human rights in exchange for benefits of corporate personhood.
The Jurisdiction of the Birth Certificate
When we are born we are of a sovereign status under natural law with the standing of a living human being with fundamental rights and freedoms of a human being. We are Nationals of the land we are born on and have a birth right to the land and the wealth created from the land to sustain our life. We extinguish these rights when we become, the legal person, a corporation through the birth certificate, in exchange for limited benefits and privileges of a citizen of a corporate state.
All Nation States are under the jurisdiction of International Law. International Law is also known as maritime law or the law of water; This is the law of commerce and shipping that governs ships, corporations, trade, contracts and all courts. Each Nation State incorporates this law into their legal codes and enactments and then deceptively calls it Statutory Jurisdiction. This Statutory Jurisdiction then incorporates common law and case law.
Why do Parents get paid (child tax benefit) to care for their own children? Children are chattel and belong to the State once they are registered through birth certificate. Parents are only caregivers of the governments property. This also why authorities can legally apprehend children; It is not out of love or care but to ensure the child is looked after just enough to attend the state run indoctrination centre’s called Schools to ensure they become a tax paying economic slave.
The Certificate of Live Birth recognizes you as a living human being. The Birth Certificate creates and registers the Legal Person, a Corporation. This is not you but if you choose to live your life in this contract you become a Debtor, Roman Slave of the State.
The Birth Certificate is a contract, a trust and a security, when we operate as the legal person we accept and have compelled performance, responsibilities as a citizen to carry out in this contract. As we navigate in this jurisdiction we are made to accept more contracts for other privileges and benefits such as the Indian status, social insurance program, drivers licence. The aspect of the trust relationship through the birth certificate is the state acts as the Executor and Beneficiary and we are the Trustee aka the Debtor. As a security our birth certificate represents our life’s labour in taxes and our right to the wealth of our land, this is then securitized, monetized and used as a bond for leverage by the state on the international trade market.
Here are the laws of how this is done:
Unum Sanctum:
In 1302 Pope Boniface issued his infamous, Unam Sanctam, claiming the Roman Catholic’s rule over the whole planet and where the Pope is effectively “King of the world.”
1455 Romanus Pontifex:
This Papal Bull created the first Crown and conveyed the right of use of the land as Real Property where all land is claimed as “crown land.” This Crown is represented by the 1st Cestui Que Vie Trust created when a child is born, deprives them of all their beneficial entitlements and rights to the land at birth.
1481 Aeterni Regis:
This Papal Bull created what is known as the “Crown of Aragon”, later known as the Crown of Spain and represents the highest sovereign and highest steward of all Roman Slaves. This 2nd Crown is represented by the 2nd cestui Que Vie Trust created when a child is born the sale of the birth certificate as a bond is sold to the private central bank of the nation, depriving them of ownership of their flesh and condemning them to perpetual servitude as a Roman person, a Catholic or slave.
1542 Convocation:
This 3rd Crown is represented by the 3rd cestui Que Vie Trust created when a child is baptized to a Parish the Registrar is gifted the title of the child’s soul. Thus, without legal title over one’s own soul, a man or woman may be “legally” denied a right to stand as a living being, but may be treated as a creature and thing without legally possessing a soul. Today Hospitals and Birth Certificates are the “baptism” and handing over of the sole/soul to the Crown.
1493 Inter Caetera:
Pope Alexander VI issues a papal bull or decree, “Inter Caetera,” in which he authorizes Spain and Portugal to colonize the Americas and its Native peoples as subjects. This Papal Bull has been dubbed the “Doctrine of Discovery.”
Reconciliation is not a word randomly chosen to represent the movement towards addressing the genocide of church and state. Reconciliation is a Catholic Ritual which is to “come back under god”. In the Catholic Cult the Pope represents God on Earth. Reconciliation is also referred to as the Sacrament of Penance. “Penance” means self punishment, the Sacrament of Penance is also entrenched and the foundation of how both Banking and Courts operate. This is all under International Law, the Jurisdiction of the Holy See, Rome.
1582 Inter gravissimas
(English: “Among the most serious…”) was a papal bull issued by Pope Gregory XIII on 24 February 1582. The document reformed the Julian calendar. The reform came to be regarded as a new calendar in its own right and came to be called the Gregorian calendar, which is
used in most countries today.
Name and date of birth in the copyrighted timeline calendar, when we use that name within that copyrighted timeline we are subjected to a commercial system, designed to own the
characters born to it.
Pope Gregory is the author of a specific literary work and his literary property is all the persons who use the names born into the copyrighted calendar. The Vatican has a legitimate claim on all the production and activity that we create when using the name born into the copyrighted timeline that has been in existence since 1582.
1666 Cestui Que Vie Act:
A United Kingdom Act of Parliament that solidifies these Trusts into U.K Law. This Act proclaims there is a remedy to take yourself out of such Trust aka State Owned Enterprise (birth certificate) to prove you are a living being and not lost at sea. The Act says if action is filed to show that the supposed dead man is proved to be alive, then the Title is revisited and profits with interest is issued to a persons estate.
The Hague Convention on the Law Applicable to Trusts:
This International Treaty is ratified by 14 countries including Canada and imposes one law that governs all Trusts and Estates. This includes the Trust created when we are born which represents our Inherent Rights as beneficiaries to the wealth created from the land we are born to. Through this Treaty this Trust is created and handed over to the State by Birth Certificate where we become Chattel and Traded in Commerce under Maritime Admiralty Law throughout our life.
International Recognition of Trusts Act:
Every Nation State that is a signatory to the Hague Convention on the Law Applicable to Trusts must implement it via their own enactment to enforce in their States or Provinces. The
International Recognition of Trust Act is Ontario’s Enactment. This ensure the Provinces enact
such Statutes where Citizens become a Trustee/Debtor of their own Express Trust via the Birth Certificate Scheme which creates us as Chattel and our Trust Estate as a Security and Bond to be traded unlimitedly within International Commerce.
Loan and Trust Corporations Act:
This is an Ontario Enactment where Section 174 (2), (3) allows the Registrar General to give a
Trustee Company your Estate to act as an Executor and obtain Probate.
The Birth Certificate
The following is how we hand over our rights to the State and enter the world of the Doctrine of Deception:
Vital Statistics Act:
Statement of Live Birth
• A Person who attends the birth of a child in Ontario must give a notice of the birth, The
Parent(s) then must provide a Surname. This creates the Statement of Live Birth and is a
permanent legal record that declares you as a living being.
• When we are born an Express Trust is created in which is not disclosed. Our Parent(s) are
the Trustor/Settlor and sign this Trust over to the State by the Vital Statistics Act; Section 5,
Safekeeping of registrations where the Registrar General becomes the Trustee/Debtor of
the Express Trust. We as the live being still are the Beneficiary/Creditor of this Trust.
The Birth Certificate
•The Vital Statistics Act says the Parent(s) shall certify the Childs Birth. The Registrar
General then takes the given name put’s it together with the surname which is then put in
all capitals, certified and registered and securitized to create the artificial legal person. The
State then issues the Birth Certificate. What appears to be your name on the Birth
Certificate is not a name but a sign, it is a foreign debased dog-latin, a counterfeit
grammatical language and owned by the State
• The State own’s the legal person, corporation, a non-living entity. We are not the entity on
the Birth Certificate.
• Through registering a child with a Birth Certificate, the Parent(s) surrenders the child’s birth
right to the land and wealth created from the land and hands those rights over to the State in Trust in exchange for benefits and privileges of becoming a citizen.
• The child now a citizen has been removed as beneficiary within the Express Trust and goes
on to live life acting as the entity on the birth certificate as a Trustee/Debtor.
• The Parent(s) and Child are not made aware of this Trust and if they the child does not
claim this Trust in Seven Years after turning the age of majority then they are determined by the State to be “Lost at Sea” or Dead in which the State claims the Estate Trust and does with it as it pleases.
• This Trust represents the living beings birth right to the wealth created from the lands and
this Birth Certificate has a CUSIP number used to monetize the Birth Certificate by putting
an estimated value of what the Legal Person Corporation will make within it’s lifetime where
and an accreditation account is attached to the CUSIP number on the Birth Certificate
which the State uses as a Security and Bond on the Stock Exchange.
• Every time we are charged with an offence and go through court the CUSIP number on our
Birth Certificate and the Court; Judges, Crown Attorney makes money off the Court Case
and charges your accreditation account on your Birth Certificate.
How the State Steals Our Birth Right
Declarations of Death Act:
The Declaration of Death Act is Ontario’s legislation by which Judge’s have jurisdiction to make an order declaring that an individual is dead. It answers the questions of who can apply, who needs to know, and what evidence you must show before the applicant can obtain a Declaration of Death.
• If We as a beneficiary then fail to prove ourselves to be alive in regards to our Express Trust up to seven years after becoming the age of majority; The State as a Trustee not hearing from the beneficiary then takes steps to make notice of our death through the Declaration of Death Act.
• Section 1 of the Declaration of Death Act says, an “interested person” means any person
who is or would be affected by an order declaring that an individual is dead, including, (a) a
person named as executor or estate trustee in the individual’s will. An “interested person” is
the State, Registrar General and or a Trust Corporation it has named to be an Executor of
the Estate.
• The Executor then follows provision, Order Re declaration of death
2 (1) An interested person may apply to the Superior Court of Justice, with notice to any other interested persons of whom the applicant is aware, for an order under subsection (3) Power of court
(3) The court may make an order declaring that an individual has died if the court is satisfied that either subsection (4) or (5) applies. (Not heard of in seven years)
• Now the State can benefit from the accreditation system attached to the CUSIP on your
Birth Certificate in which represents a persons share in the wealth being created from their
birth right to the resources of their Country.
• We now only are the Debtor/Trustee’s and only have benefits of a legal persons and not
rights and obligated to hand our wages over to the state in servitude and any other taxes
they see fit as they are now the Beneficiary’s of everyones Trust.
Further Enactments of the Legal Fiction Enslavement:
To further ensure people surrender their status as a Living Being, Corporate State’s further
impose Enactments to designate People as a Legal Person. Through the designations of being a Resident of a Town, City Municipality; an Employee through the following enactment’s is how the State holds you in servitude by accepting these Benefits of Citizenship of their Corporation:
Social Insurance and Income Tax Entrapment
• To legally work one has to register for a Social Insurance Number under the Employment
Insurance Act and Income Tax Act in which a Birth Certificate is also required.
• Income Tax Act (R.S.C., 1985, c.1) 2. (1) An income tax shall be paid, as required by this
Act on the taxable income for each taxation year of every person resident in Canada at any
time in the year.
• Every Person with a SIN Number is an Officer of of the Corporation, the Government of
Canada or their Nation STATE they are resident of.
The Municipal Act, Municipal Act, 2001, S.O. 2001, C.25
“Municipality” means a geographic area whose inhabitants are incorporated. Municipality, includes the corporation of a city, town, village, county, townships, parish or other territorial or local division or a province, the inhabitants of which are incorporated
Stay tuned for upcoming series on this particular step which deserves its own document. This step shares on how to File a Constitutional Question or Human Rights Complaint. This step is necessary to get out of the legal person and walk the court which is obligated by law to turn the court from statutory jurisdiction to inherent jurisdiction to deal with the live human being rather then the legal person which has no human rights.
The Birth Certificate is also a Security, I am still researching the last bit of understanding in Trust Law where we need to reclaim our securities and declare ourselves as alive with the State. I will share this in a later series also as this deserves its own document to explain as well.
We need to Reconstitute our Common Law of the Land representative of our Constitution; the Creation Teachings, Clan System and Confederacies. Remove the law of water from the law of the land.
We need to create our own ‘Vital Statistics Act”, create our own Birth Certificates and Registry of our own Nation and get out of this international legal system, which is only a jurisdiction that creates a roman slave an economic slave that extinguishes our human rights for privileges on a citizenship.
Bring a Class Action Suite against the Roman Catholic Church and the Pope through
International Criminal Court and International Court of Justice. (Yet the Pope and Vatican Inc can’t be held accountable to such international court, which tells you something.) We must delegitimize the Roman Catholic Church and Christianity as a Religion and as the fraud it is. It’s Papal Bulls have no effect over the World only those who wish to belong as officers of this corporation.
Help the so called Canadian Citizen reclaim their Sovereignty and establish a proper Constitution and create new needed Treaties as the historic ones have been extinguished via 1931 Statute of Westminster.
Most importantly we need o raise our youth with our rites of passage ceremonies; Berry Fast, and Fasting for example which teaching self discipline at ages of puberty. We need to install our culture where young adults learn the responsibilities and consequences of sexual relationships and being responsible for creating life. Yes we have a history but it is not our story. At sometime we need to grow from our intergenerational trauma and become responsible for ourselves. If we can’t take care of our own children first as parents, families, community we are not Sovereign or a Nation.
Portugal is rapidly emerging as a leading center for medical marijuana in Europe. Its mild, temperate, subtropical environment, frequently likened to that of California, makes it an excellent location for cultivating cannabis.
“No other European country offers better environmental conditions,” said Martins of FAI Therapeutics, a Portuguese pharmaceutical firm. Located near the hills of Serpa, surrounded by cork oaks and olive trees, FAI Therapeutics’ 13.3-acre farm produces approximately 30 tons of marijuana flowers annually. The operation began in 2022 following a surge of interest from international marijuana producers drawn to Portugal’s ideal climate and supportive legislation.
Currently, over 60 companies have received authorization to cultivate, distribute, or process medical marijuana products in Portugal, with an additional 170 companies waiting for approval. Last year, the country exported about 12 tons of marijuana-based medical products, primarily to Germany, Europe’s biggest market, and to countries such as Australia, Poland, and Spain.
The industry has ambitious goals as demand for medical marijuana grows globally. According to Jose Tempero, medical director of Tilray Brands Inc. (NASDAQ: TLRY) (TSX: TLRY), a global corporation based in Canada with a marijuana farm close to Cantanhede, Portugal is leading among European producers of medical cannabis. Tilray’s facility has packaging and processing facilities as well as labs, with its marijuana oils selling even in Latin America.
The expanding market for medical marijuana is driven by its applications in managing chronic pain, cancer treatment side effects, and certain forms of epilepsy, among other medical conditions. Over 50 countries have approved marijuana-based medications, with the number expected to increase in the coming years. Market analysts predict the global medical marijuana industry will grow from $16.6 billion in 2023 to more than $65 billion by 2030.
Beyond its favorable climate, Portugal offers a robust regulatory framework established under its 2019 cannabis legislation, which enforces strict quality standards. These regulations have bolstered confidence among international buyers, ensuring the safety and reliability of products exported from Portugal.
Despite Portugal’s leadership in production, many Portuguese patients face challenges in accessing cannabis-based medications. Most doctors are hesitant to prescribe these treatments, and their costs are not fully covered by the nation’s healthcare system. Lara Silva, whose young daughter suffers from severe epilepsy, highlighted the difficulty of accessing CBD products locally. She initially had to source them from Spain due to insufficient availability in Portugal.
Tempero acknowledged the stigma surrounding medical cannabis but expressed optimism about its growing acceptance, particularly beyond recreational use.
About CNW420
CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of an article each business day at 4:20 p.m. Eastern – a tribute to the time synonymous with cannabis culture. The concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.
To receive SMS alerts from CNW, text CANNABIS to 888-902-4192 (U.S. Mobile Phones Only)
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: https://www.CannabisNewsWire.com/Disclaimer
Aurora Cannabis has announced a distribution partnership to broaden access to its medical cannabis products in the Australian market.
The deal, announced on December 17, 2024 is between The Entourage Effect—which provides comprehensive distribution and support services to pharmacies in Australia—and the Aurora subsidiary MedReleaf Australia.
The Entourage Effect will serve as a wholesaler for MedReleaf Australia’s portfolio of products under the CraftPlant, Aurora, and IndiMed brands. Aurora acquired MedReleaf Australia, formerly Indica Industries Pty Ltd, in Feb. 2024.
“We are thrilled to be partnering with MedReleaf Australia to facilitate the distribution and wholesaling of their products,” said Lisa Varley, CEO of The Entourage Effect. “This collaboration marks a significant milestone for both companies, underscoring our shared commitment to improving patient access and advancing the Australian medicinal cannabis market. Together, we are well-positioned to better serve the needs of patients across the nation.”
Andre Jerome, executive vice president of global business development at Aurora, says the deal will help expand Aurora’s footprint in the Australian medical cannabis market.
“We are deeply committed to broadening access to premium medical cannabis for the expanding community of patients who rely on Aurora, and we seek the right partners in the markets in which we operate to make this happen,” said Jerome. “Our new partnership with The Entourage Effect broadens our already robust distribution in Australia, ensuring even greater access to our high-quality medical cannabis portfolio, reinforcing our commitment to patient care.”
Aurora Cannabis brought in $81.1 million in net revenue in the three months ending September 30, 2024 (Q2 2025), and reported a net loss of nearly $13 million in the company’s most recent quarterly report.
Just under $15.1 million of Aurora’s international sales were in the Australian market in Q2, while $20 million were in Europe and $26.3 million were in Canada.
Aurora’s major subsidies include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, Bevo Agtech Inc., CannaHealth Therapeutics Inc., and ACB Captive Insurance Company Inc.
The Entourage Effect lists several other cannabis brands under its distribution wing, including Canadian brands like Lot 420, Redecan, Tilray Medical, and Broken Coast.
MediPharm Labs Corp. has entered into an agreement for the purchase and sale of its facility in Napanee, Ontario, through a disposition of all of the company’s indirect equity interests in its wholly-owned subsidiary ABcann Medicinals Inc. to Kensana Health for $5.5 million in cash.
Pursuant to the purchase agreement, Kensana Health has agreed to acquire all of the issued and outstanding shares in the capital of ABcann from the company’s operating subsidiary MediPharm Labs Inc.
IF the acquisition of ABcann goes through, Kensana Health will acquire the license in respect of the Napanee Facility as well as the building, land, and equipment. Current commercial agreements and activities of the company will stay with MediPharm Labs.
The deal is expected to close by January 1, 2025, subject to customary closing conditions and receipt of all necessary approvals, as applicable.
As part of the transactions contemplated by the purchase agreement, MediPharm Labs and Kensana Health will form a strategic partnership, through the execution of a comprehensive supply and services agreement, leveraging MediPharm’s advanced GMP manufacturing capabilities. Under this partnership, Kensana Health has agreed to supply select products and services to augment MediPharm’s international brands and to support the company’s growing international customer base.
This strategic transaction, says MediPharm in a press release, aligns with the company’s focus on streamlining its operations and maximizing value for stakeholders. This transaction is also expected to further complement MediPharm’s cash position and allow it to invest in future growth opportunities.
“This Transaction reflects our commitment to enhancing operational efficiency while fostering strong partnerships that expand our global reach,” said David Pidduck, CEO of MediPharm Labs. “By monetizing non-core assets and securing a strategic supply and services agreement, we are looking to ensure that MediPharm is well-positioned to continue delivering high-quality, GMP-certified cannabinoid solutions to our valued partners and customers worldwide.”
For Kensana Health, the deal is expected to support its ongoing United States Food and Drug Administration (FDA) registration process for its novel topical chronic wound treatment, with plans for subsequent approvals in Europe, U.K., Canada, the Middle East, Pacific Rim and Australia.
Ken Clement, CEO and Founder of Kensana Health commented, “As the original founder of ABcann in 2012, I am very grateful to the MediPharm team for facilitating the opportunity for Kensana Health to complete this acquisition.”
Clement goes on to say, “This acquisition represents our commitment to advancing phytopharmaceutical development, specifically targeting severe medical conditions with significant unmet needs. This is a strategic move to expand our pharmaceutical manufacturing capabilities for multiple plants, and not just phytocannabinoids.”
Medipharm Labs brought in $9.8 million in net revenue in its most recent quarterly report for the three months ended September 30, 2024 (Q3 2024), $3.1 million in gross profit, but a net loss of $2.8 million.
Net revenue was up 15% from $8.5 million in the same quarter the previous year, while net loss declined from $4.3 million. Gross profit increased year-over-year from $2.4 million and $3.4 million in the previous quarter (Q2 2024).
The bulk of the company’s net revenue came from sales into the Canadian market ($6.2 million), increased from $5.9 million in the same quarter in 2023. Another $2.5 million in sales were in Australia, up year-over-year from $2.2 million, $1 million in Germany (up from $319,000 in Q3 2023), and $62,000 in other international sales (up from $5,000).
MediPharm Labs was founded in 2015. The Barrie, Ontario facility holds GMP certifications from Health Canada, the Australian Therapeutic Goods Association, and ANVISA (Brazil). The Barrie Facility obtained EU-GMP certification from the LAVG in July 2024. These GMP certifications have been accepted in other international markets, such as Brazil and the European Union.
MediPharm owns two wholly-owned subsidiaries, Canna Farms and ABcann. ABcann’s operations focus on European Union Good Manufacturing Practices related to cultivation and packaging for international markets.
Recent Comments